Literature DB >> 11530053

Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram.

J K Luu1, A V Chappelow, T J McCulley, M F Marmor.   

Abstract

PURPOSE: To evaluate the acute effects of sildenafil (Viagra; Pfizer, Inc, New York, New York) on the electroretinogram and multifocal electroretinogram.
METHODS: Eighteen healthy individuals (ages 21-49 years) were studied; 14 were given 200 mg sildenafil orally and four were given only water. All subjects were tested before sildenafil and 1 hour after sildenafil (or water) with a desaturated Panel D-15 color test, a full-field standard electroretinogram, and a multifocal electroretinogram using the VERIS system; five subjects were also tested 5 hours after sildenafil.
RESULTS: Responses from the subjects who received sildenafil were compared with those from the control subjects. At 1 hour after sildenafil, photopic single-flash waveforms were attenuated by 9% and scotopic maximal response amplitudes were increased slightly. Photopic and 30-Hz flicker electroretinogram responses were delayed; multifocal electroretinogram waveforms were delayed (5%-9%) and attenuated (14%-22%) across the posterior pole. These changes did not resolve by 5 hours. Nine of the subjects who had received sildenafil (64%) reported visual or systemic symptoms, including one who reported bluish vision. Ten of those subjects (71%) showed a slight increase in color test errors 1 hour after sildenafil.
CONCLUSIONS: For at least 5 hours after taking 200 mg of sildenafil, cone function was slightly depressed in the macula and periphery, as measured by full-field electroretinogram and multifocal electroretinogram recordings. However, the affected electroretinogram and multifocal electroretinogram parameters still remained within normal limits.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530053     DOI: 10.1016/s0002-9394(01)01052-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Dose-dependency and time-course of electrophysiologic short-term effects of VIAGRA: a case study.

Authors:  Herbert Jägle; Christine Jägle; Ludwig Sèrey; Lindsay T Sharpe
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

2.  Visual impairment with possible macular changes after a high dose of sildenafil in a healthy young woman.

Authors:  Yun-Yun Li; Ya-Jie Yu; Xi-Pu Liu; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

3.  Four-year review of sildenafil citrate.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2002

4.  ERG evaluation of daily, high-dose sildenafil usage.

Authors:  Christopher I Zoumalan; Roham T Zamanian; Ramona L Doyle; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2008-09-26       Impact factor: 2.379

5.  SILDENAFIL CITRATE INDUCED RETINAL TOXICITY-ELECTRORETINOGRAM, OPTICAL COHERENCE TOMOGRAPHY, AND ADAPTIVE OPTICS FINDINGS.

Authors:  Fatoumata Yanoga; Ronald C Gentile; Toco Y P Chui; K Bailey Freund; Millie Fell; Rosa Dolz-Marco; Richard B Rosen
Journal:  Retin Cases Brief Rep       Date:  2018 Fall

6.  Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Authors:  Barbara M Wirostko; Charles Tressler; Lie-Ju Hwang; Gary Burgess; Alan M Laties
Journal:  BMJ       Date:  2012-02-21

Review 7.  Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Drug Des Devel Ther       Date:  2016-10-19       Impact factor: 4.162

8.  Changes in Retinal and Choroidal Vascular Blood Flow after Oral Sildenafil: An Optical Coherence Tomography Angiography Study.

Authors:  David Berrones; Guillermo Salcedo-Villanueva; Virgilio Morales-Cantón; Raul Velez-Montoya
Journal:  J Ophthalmol       Date:  2017-10-09       Impact factor: 1.909

9.  Ocular side effects of Levitra® (vardenafil) - results of a double-blind crossover study in healthy male subjects.

Authors:  Gernot Roessler; Michael Vobig; Peter Walter; Babac Ae Mazinani
Journal:  Drug Des Devel Ther       Date:  2018-12-18       Impact factor: 4.162

10.  Effect of DA-8159, a selective phosphodiesterase type 5 inhibitor, on electroretinogram and retinal histology in rabbits.

Authors:  Ho Kyun Cho; Kyung Koo Kang; Gook Jun Ahn; Hyun Joo Shim; Won Bae Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.